VYZULTA (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION) 0.024%
Product details
Registration number: SIN16214P
Classification: Prescription Only
Active ingredients: Latanoprostene bunod
Strength: 0.24mg/ml
Dosage form: SOLUTION, STERILE
Route: OPHTHALMIC
Registrant: BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED
ATC code: S01EE06
HSA approval date: 1 June 2021
Manufacturer(s): Bausch & Lomb, Incorporated.
Manufacturing country/countries: UNITED STATES
What are the HSA registration number and classification for VYZULTA (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION) 0.024%?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16214P
Classification: Prescription Only
What active ingredients and strength are recorded for VYZULTA (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION) 0.024%?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Latanoprostene bunod
Strength: 0.24mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for VYZULTA (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION) 0.024%?
According to the HSA dataset updated 7 August 2026:
Dosage form: SOLUTION, STERILE
Route: OPHTHALMIC
Who is the recorded registrant for VYZULTA (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION) 0.024%?
According to the HSA dataset updated 7 August 2026:
Registrant: BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED
Which manufacturers and countries are listed for VYZULTA (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION) 0.024%?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Bausch & Lomb, Incorporated.
Manufacturing country/countries: UNITED STATES
Where can I look up VYZULTA (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION) 0.024% in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16214P or the exact product name VYZULTA (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION) 0.024%. The general register link does not preselect this product.
What are the source dates for this VYZULTA (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION) 0.024% record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this VYZULTA (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION) 0.024% record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16214P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)